Our Pricing

Buy Best Fat Loss Medication Online UK

Published on: June 03, 2026

When you buy best fat loss medication online UK from Cured Pharmacy, you access clinically proven treatments including Mounjaro, Wegovy, Saxenda, and Orlistat—all dispensed following free consultation with UK-registered prescribers. Our transparent pricing starts from £135.00, with genuine MHRA-licensed medications delivered discreetly to your door, backed by our superintendent pharmacist Tarun Kumar (GPhC 2233073) and our commitment to the lowest prices guaranteed across the UK.

How GLP-1 Receptor Agonists Work for Fat Loss

GLP-1 receptor agonists represent the most effective class of fat loss medication currently licensed in the UK, with clinical trials demonstrating average weight reductions of 15-22.5% over 52-72 weeks [1][2]. These injectable medications—including tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda)—mimic natural gut hormones that regulate appetite, slow gastric emptying, and improve glucose metabolism.

Tirzepatide offers a dual mechanism, activating both GLP-1 and GIP receptors simultaneously. In the SURPASS-2 trial, participants receiving the 15mg dose achieved an average 22.5% total body weight reduction over 72 weeks—significantly superior to single-pathway alternatives [1]. This dual-receptor approach explains why Mounjaro has become the most sought-after prescription fat loss medication in the UK since receiving MHRA approval.

All GLP-1 medications require once-weekly subcutaneous injection (except Saxenda, which requires daily administration) and must be prescribed following clinical assessment by a UK-registered prescriber. Side effects typically include transient nausea, which diminishes as your body adapts during dose escalation [1][2].

Comparing Injectable vs Oral Fat Loss Medication

The UK market now offers both injectable GLP-1 receptor agonists and oral fat absorption inhibitors, each suited to different patient profiles and weight loss goals. Injectable options deliver superior average weight reduction—clinical trials show 15-22.5% body weight loss with GLP-1 medications compared to 5-10% with oral alternatives [1][3].

Oral medications like Orlistat (available as prescription 120mg or over-the-counter 60mg formulations) work by blocking approximately 30% of dietary fat absorption in your intestines [3]. Whilst producing more modest weight loss, Orlistat suits patients preferring tablet-based treatment or those with contraindications to GLP-1 therapy. The medication requires adherence to a reduced-fat diet to minimise gastrointestinal side effects.

Which Format Suits Your Lifestyle?

Injectable medications offer convenience through once-weekly administration (or daily for Saxenda), with pre-filled pens requiring no preparation. Patients typically adapt to self-injection within 1-2 weeks, and modern pen devices feature ultra-fine needles that minimise discomfort. Oral medications require three times daily dosing with meals, demanding greater schedule adherence but avoiding injection entirely. Your UK prescriber will assess your medical history, weight loss goals, and lifestyle factors to recommend the most appropriate option during your free consultation.

Buy Best Fat Loss Medication: Mounjaro, Wegovy & Saxenda Compared

Mounjaro (tirzepatide) currently delivers the highest average weight reduction of any licensed fat loss medication in the UK. The SURMOUNT-1 trial demonstrated that 91% of participants achieved at least 5% weight loss, with 57% achieving ≥20% reduction at the 15mg maintenance dose [1]. This dual GIP/GLP-1 receptor agonist starts at lower doses and escalates gradually over 16-20 weeks to minimise side effects whilst maximising efficacy.

Wegovy (semaglutide) offers proven efficacy with average 15% body weight reduction over 68 weeks in the STEP-1 trial [2]. As a single-pathway GLP-1 agonist, it provides an established safety profile with extensive real-world use across UK clinical practice. Many prescribers favour Wegovy for patients with type 2 diabetes history due to its dual metabolic benefits.

Saxenda (liraglutide) requires daily injection but offers flexible dosing that some patients prefer for tighter appetite control throughout the day. Clinical trials show average 8% body weight reduction over 56 weeks [4]. Whilst producing more modest results than newer agents, Saxenda suits patients preferring daily administration or those stepping up from oral medications.

Treatment Selection Criteria

Your UK prescriber considers multiple factors when recommending fat loss medication: baseline BMI, presence of weight-related comorbidities (type 2 diabetes, hypertension, sleep apnoea), previous weight loss attempts, contraindications, and cost considerations. Patients with BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related conditions) typically qualify for GLP-1 therapy subject to clinical assessment. All prescription medications dispensed by Cured Pharmacy require completion of our free online consultation, reviewed by UK-registered prescribers within 24 hours.

Orlistat: The Established Oral Fat Loss Medication

Orlistat remains the only oral fat loss medication licensed in the UK, available in prescription-strength 120mg (Xenical, generic orlistat) and over-the-counter 60mg formulations (Alli, Orlos). By inhibiting pancreatic and gastric lipases, orlistat prevents approximately 30% of dietary fat absorption, with unabsorbed fat excreted in stools [3].

Clinical trials demonstrate average 5-10% body weight reduction when combined with a reduced-calorie, lower-fat diet (typically <30% calories from fat) [3]. The medication works only in the presence of dietary fat, making it ineffective if taken without food or with fat-free meals. Patients must take one capsule with each main meal (up to three times daily), ideally during or within one hour of eating.

Gastrointestinal side effects—including oily stools, faecal urgency, and increased bowel movements—occur frequently but diminish when patients adhere to the recommended low-fat diet. Orlistat also reduces absorption of fat-soluble vitamins (A, D, E, K), so supplementation taken at least 2 hours apart from orlistat doses is advisable for long-term use [3].

Pricing Transparency: What You Pay at Cured Pharmacy

At Cured Pharmacy, we display exact pricing before you complete your clinical consultation—no hidden fees, no surprise charges at checkout. Our superintendent pharmacist Tarun Kumar has structured our pricing to remain the lowest in the UK market whilst maintaining full regulatory compliance and genuine MHRA-licensed medications.

All prices include your medication, free clinical consultation with a UK-registered prescriber, and discreet delivery to your chosen address. We never charge consultation fees separately, and our prescribers assess your suitability based purely on clinical appropriateness—not your ability to pay premium prices. Patients requiring ongoing treatment benefit from our competitive repeat prescription pricing, with automatic reminders ensuring you never run out of medication.

We guarantee UK-licensed medications sourced through legitimate pharmaceutical supply chains, never grey-market imports or unlicensed alternatives. Every prescription is dispensed by GPhC-registered pharmacists from our UK facility (GPhC 9012511), with full patient information leaflets and support from our clinical team available via phone during business hours.

Payment Plans & Subscription Options

For patients requiring long-term fat loss medication, we offer flexible payment options including one-time purchases and subscription services. Subscriptions ensure uninterrupted treatment with automatic refills timed to your dosing schedule, with the flexibility to pause, adjust, or cancel at any time through your patient account. All payment processing uses secure, PCI-compliant systems, and we never store your full card details on our servers.

Clinical Consultation Process & Prescriber Assessment

Every prescription fat loss medication dispensed by Cured Pharmacy requires clinical assessment by a UK-registered prescriber, in full compliance with General Pharmaceutical Council regulations and MHRA guidelines. Our online consultation takes under 3 minutes to complete and covers your medical history, current medications, weight loss goals, and any contraindications to specific treatments.

Our prescribers assess your BMI, weight-related health conditions, previous weight loss attempts, and suitability for specific medication classes. Contraindications vary by medication—for example, GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1][2]. Your prescriber may request additional information or recommend alternative treatments based on your individual clinical picture.

Once approved, your prescription is sent electronically to our dispensing pharmacy, where GPhC-registered pharmacists conduct a final clinical check before dispensing your medication. Most orders are dispatched within 24 hours via tracked delivery in discreet, unmarked packaging. If your prescriber determines that fat loss medication is not clinically appropriate for you, we will explain the decision and suggest alternative approaches, with no charge for the consultation.

Ongoing Clinical Support

Patients on long-term fat loss medication receive ongoing support from our clinical team, including dose adjustment consultations, side effect management advice, and periodic reviews to assess treatment efficacy. We recommend patients monitor their weight weekly and report any concerning symptoms immediately. Our prescribers can adjust your dose, switch medications, or discontinue treatment if clinically indicated, always prioritising your safety and wellbeing over commercial considerations.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes.